Skip to main content
Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc. — Investor Relations & Filings

Ticker · LYRA ISIN · US55234L1052 US Manufacturing
Filings indexed 356 across all filing types
Latest filing 2025-11-13 Director's Dealing
Country US United States of America
Listing US LYRA

About Lyra Therapeutics, Inc.

https://lyratherapeutics.com/

Lyra Therapeutics, Inc. is a clinical-stage biotechnology company that develops and commercializes innovative therapies for the localized treatment of chronic rhinosinusitis (CRS). The company's product candidates are long-acting, anti-inflammatory sinonasal implants designed to deliver medication directly to sinonasal tissues. This approach aims to provide a new, long-lasting treatment option for patients with this debilitating inflammatory disease, targeting tissues that are not easily accessible with conventional therapeutic methods.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2025-11-13 English
SCHEDULE 13D/A Filing
Major Shareholding Notification
2025-11-13 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-12 English
8-K
Regulatory Filings
2025-11-12 English
4
Director's Dealing
2025-11-10 English
SCHEDULE 13D/A Filing
Major Shareholding Notification
2025-11-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.